CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Colombia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. In 2015, the population of Colombia was approximately 48.2 million, growing at a Compound Annual Growth Rate (CAGR) of 1.2%, over the 2008-2015 period. The value of the pharmaceutical market was estimated at $5 billion in 2015, and is expected to reach $7.1 billion by 2020, increasing at a projected CAGR of 7.3%. The positive trends in the healthcare market of Colombia can be attributed primarily to: • Increasing awareness of health and well-being in society • Increasing affordability and compliance • A strategic move by the Colombian government towards compulsory health insurance

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Colombia, and includes:

  • An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Tecnoquimicas, Pfizer, Merck, Roche and Procaps..
  • An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
  • An overview of the opportunities and challenges for growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving Colombia healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Colombia’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Overview of the Pharmaceutical and Medical Device Markets

3.1Pharmaceutical ...

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Overview of the Pharmaceutical and Medical Device Markets

3.1Pharmaceutical Market

3.1.1Market Overview

3.1.2Pharmaceutical Exports and Imports

3.1.3Supply Channels

3.1.4Market Segments

3.1.5Major Disease Areas

3.1.6Major Companies

3.2Medical Device Market

3.3Market Drivers and Barriers

3.3.1Drivers

3.3.2Barriers

4Market Access

4.1Reimbursement and Payer Landscape

4.1.1Overview of Healthcare System

4.1.2Reimbursement Process

4.1.3Overview of Insurance Providers

4.1.4Patient Share in Healthcare Spending

4.1.5Price Trends in Healthcare Sector

4.1.6Pricing Policies

4.2Regulatory Landscape

4.2.1Overview of Regulatory Agencies

4.2.2Market Authorization Procedure for Pharmaceutical Products

4.2.3New Medical Device Approval Process

4.2.4Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5Licensing Process for Pharmaceutical Exports and Imports

4.2.6Intellectual Property Rights

4.2.7Clinical Trial Regulations

4.2.8Pharmaceutical Advertising Regulations

4.2.9Pharmacy Regulations

4.2.10Labeling and Packaging Regulations

5Country Analysis

5.1Political Environment

5.1.1Political Structure

5.1.2Analysis of the Current Political Environment

5.1.3Healthcare Policy Initiatives

5.2Economic Landscape

5.3Economic Indicators

5.3.1Gross Domestic Product

5.3.2Gross National Income

5.3.3Inflation

5.3.4Currency Exchange Rate

5.3.5Foreign Direct Investment

5.3.6Foreign Exchange Reserves

5.3.7Trade Balance

5.3.8General Government Structural Balance

5.3.9General Government Net Debt

5.3.10Major Industries

5.4Demographics

5.4.1Population

5.4.2Education and Literacy

5.4.3Employment

5.4.4Disease Burden

5.5Healthcare Infrastructure

5.5.1Healthcare Parameters

5.5.2Environmental Health

5.5.3Healthcare Personnel

5.6Healthcare Expenditure

5.6.1Overview

5.6.2Major Components of Healthcare Spending

5.6.3Public and Private Sector Share

5.7Trade Associations

5.7.1Colombian Pharmaceutical Industry Association

5.7.2Association of Pharmaceutical Laboratories Research

5.7.3National Academy of Medicine of Colombia

5.7.4Colombian Association of Integrative Medicine Business

5.7.5The Colombian Association of Medical Schools

5.8Trade Fairs

6Opportunities and Challenges

6.1Opportunities

6.2Challenges

7Appendix

7.1Abbreviations

7.2Bibliography

7.3Research Methodology

7.3.1Coverage

7.3.2Secondary Research

7.3.3Forecasts

7.3.4Expert Panel

7.4Disclaimer

List of Tables

Table 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Colombia, Revenue ($bn), 2016–2020

Table 3: Pharmaceutical Market, Colombia, Exports and Imports ($m), ...

Table 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Colombia, Revenue ($bn), 2016–2020

Table 3: Pharmaceutical Market, Colombia, Exports and Imports ($m), 2008–2015

Table 4: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016

Table 5: Pharmaceutical Market, Merck & Co., Global, Major Products, 2015

Table 6: Pharmaceutical Market, Merck & Co., Global, Late-Stage Pipeline, 2016

Table 7: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($m) and Annual Growth (%), 2013

Table 8: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2016

Table 9: Medical Device Market, Colombia, Revenue ($bn), 2008–2015

Table 10: Medical Device Market, Colombia, Revenue ($bn), 2016–2020

Table 11: Market Access, Colombia, Out-of-Pocket Payments as a Percentage of Total Healthcare Expenditure (%), 2008–2015

Table 12: Market Access, Colombia, Change in Average Price of Healthcare Services (%), 2008–2015

Table 13: Regulatory Landscape, Colombia, Trademark Filing Fees and Charges, 2016

Table 14: Economic Indicators, Colombia, Gross Domestic Product per Capita ($), 2008–2015

Table 15: Economic Indicators, Colombia, GDP per Capita Forecast ($), 2016–2020

Table 16: Economic Indicators, Colombia, GDP Annual Growth (%), 2008–2015

Table 17: Economic Indicators, Colombia, GDP Annual Growth (%), 2016–2020

Table 18: Economic Indicators, Colombia, Gross National Income per Capita ($), 2008–2015

Table 19: Economic Indicators, Colombia, Consumer Price Index, 2008–2015

Table 20: Economic Indicators, Colombia, Consumer Price Index, 2016–2020

Table 21: Economic Indicators, Colombia, Consumer Price Annual Change (%), 2008–2015

Table 22: Economic Indicators, Colombia Currency Exchange Rate ($/COP) 2008–2015

Table 23: Economic Indicators, Colombia, Foreign Direct Investment ($bn), 2008–2015

Table 24: Economic Indicators, Colombia, Foreign Exchange Reserves ($bn), 2008–2015

Table 25: Economic Indicators, Colombia, Imports of Goods and Services ($bn), 2008–2015

Table 26: Economic Indicators, Colombia, Exports of Goods and Services ($bn), 2008–2015

Table 27: Economic Indicators, Colombia, Government Structural Balance ($bn), 2008–2015

Table 28: Economic Indicators, Colombia, General Government Net Debt ($bn), 2008–2015

Table 29: Economic Indicators, Colombia, General Government Net Debt Forecast ($bn), 2016–2020

Table 30: Economic Indicators, Colombia, Major Industries, Population Employed (million), 2015

Table 31: Demographics, Colombia, Population (million), 2008–2015

Table 32: Demographics, Colombia, Population (million), 2016–2020

Table 33: Demographics, Colombia, Urban–Rural Population Share (%), 2008–2015

Table 34: Demographics, Colombia, Urban–Rural Population Share (%), 2016–2020

Table 35: Demographics, Colombia, Population Distribution by Age Group (%), 2008–2015

Table 36: Demographics, Colombia, Population Distribution by Age Group Forecast (%), 2016–2020

Table 37: Demographics, Colombia, Births (per 1,000 population), 2008–2015

Table 38: Demographics, Colombia, Mortality (per 1,000 population), 2008–2015

Table 39: Demographics, Colombia, Major Causes of Mortality (%), 2015

Table 40: Demographics, Colombia, Mortality Rate in Children under Five (per 1,000 live births), 2008–2015

Table 41: Demographics, Colombia, Immunization Rate (%), 2008–2013

Table 42: Demographics, Colombia, Major Causes of Male Mortality (‘000), 2011

Table 43: Demographics, Colombia, Major Causes of Female Mortality (‘000), 2011

Table 44: Demographics, Colombia, Gender Ratio (M/F), 2008–2015

Table 45: Demographics, Colombia, Life Expectancy at Birth (years), 2008–2015

Table 46: Demographics, Colombia, Gross Enrollment by Level of Education (%), 2008–2015

Table 47: Demographics, Colombia, Unemployment Rate (%), 2008–2015

Table 48: Demographics, Colombia, Number of Deaths by Disease (‘000), 2013

Table 49: Demographics, Colombia, Disability-Adjusted Life Years by Major Disease (‘000), 2012

Table 50: Healthcare Infrastructure, Colombia, Hospital Beds (per 1,000 population), 2008–2015

Table 51: Healthcare Infrastructure, Colombia, Doctors (per 1,000 population), 2008–2015

Table 52: Healthcare Infrastructure, Colombia, PM2.5 (µg/m3), 2008–2015

Table 53: Healthcare Infrastructure, Colombia, CO2 Emissions (metric tons per capita), 2008–2015

Table 54: Healthcare Infrastructure, Colombia, Nurses (per 1,000 population), 2008–2015

Table 55: Healthcare Infrastructure, Colombia, Dentists (per 1,000 population), 2008–2015

Table 56: Healthcare Expenditure, Colombia, Healthcare Expenditure (% of GDP), 2008–2015

Table 57: Healthcare Expenditure, Colombia, Share of Major Components (%), 2014

Table 58: Healthcare Expenditure, Colombia, Healthcare Expenditure, Public–Private Share (%), 2008–2015

Table 59: Healthcare Expenditure, Colombia, Major Healthcare Trade Fairs, 2016

List of Figures

Figure 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008–2020

Figure 2: Medical Device Market, Colombia, Revenue ($m), 2008–2020

Figure 3: Country Profile, Colombia, 2016

Figure 4: ...

Figure 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008–2020

Figure 2: Medical Device Market, Colombia, Revenue ($m), 2008–2020

Figure 3: Country Profile, Colombia, 2016

Figure 4: Pharmaceutical Market, Colombia, Revenue ($bn), 2008–2015

Figure 5: Pharmaceutical Market, Colombia, Revenue ($bn), 2016–2020

Figure 6: Pharmaceutical Market, Colombia, Exports and Imports ($m), 2008–2015

Figure 7: Medical Device Market, Colombia, Revenue ($bn), 2008–2015

Figure 8: Medical Device Market, Colombia, Revenue ($bn), 2016–2020

Figure 9: Healthcare Market, Colombia, Drivers and Barriers, 2016

Figure 10: Market Access, Colombia, Overview of Healthcare System

Figure 11: Market Access, Colombia, Overview of Healthcare System

Figure 12: Market Access, Colombia, Out-of-Pocket Payments as a Percentage of Total Healthcare Expenditure (%), 2008–2015

Figure 13: Market Access, Colombia, Change in Average Price of Healthcare Services (%), 2008–2015

Figure 14: SISMED Monitoring Process, Colombia, 2012

Figure 15: Structure of INVIMA, Colombia, 2012

Figure 16: Market Access, Colombia, Marketing Authorization Procedure, 2015

Figure 17: Regulatory Landscape, Colombia, Generic Drug Approval Process, 2015

Figure 18: Licensing Process for Manufacturing, Colombia, 2012

Figure 19: Market Access, Colombia, Patent Approval Process, 2014

Figure 20: Economic Indicators, Colombia, Gross Domestic Product per Capita ($), 2008–2015

Figure 21: Economic Indicators, Colombia, GDP per Capita ($), 2016–2020

Figure 22: Economic Indicators, Colombia, GDP Annual Growth (%), 2008–2015

Figure 23: Economic Indicators, Colombia, GDP Annual Growth (%), 2016–2020

Figure 24: Economic Indicators, Colombia, Gross National Income per Capita ($), 2008–2015

Figure 25: Economic Indicators, Colombia, Consumer Price Index, 2008–2015

Figure 26: Economic Indicators, Colombia, Consumer Price Index, 2016–2020

Figure 27: Economic Indicators, Colombia, Consumer Price Annual Change (%), 2008–2015

Figure 28: Economic Indicators, Colombia, Currency Exchange Rate ($/COP) 2008–2015

Figure 29: Economic Indicators, Colombia, Foreign Direct Investment ($bn), 2008–2015

Figure 30: Economic Indicators, Colombia, Foreign Exchange Reserves ($bn), 2008–2015

Figure 31: Economic Indicators, Colombia, Imports of Goods and Services ($bn), 2008–2015

Figure 32: Economic Indicators, Colombia, Exports of Goods and Services ($bn), 2008–2015

Figure 33: Economic Indicators, Colombia, Government Structural Balance ($bn), 2008–2015

Figure 34: Economic Indicators, Colombia, General Government Net Debt ($bn), 2008–2015

Figure 35: Economic Indicators, Colombia, General Government Net Debt ($bn), 2016–2020

Figure 36: Economic Indicators, Colombia, Major Industries, Population Employed (million), 2015

Figure 37: Demographics, Colombia, Population (million), 2008–2015

Figure 38: Demographics, Colombia, Population (million), 2016–2020

Figure 39: Demographics, Colombia, Urban–Rural Population Share (%), 2008–2015

Figure 40: Demographics, Colombia, Urban–Rural Population Share (%), 2016–2020

Figure 41: Demographics, Colombia, Population Distribution by Age Group (%), 2008–2015

Figure 42: Demographics, Colombia, Population Distribution by Age Group (%), 2016–2020

Figure 43: Demographics, Colombia, Births (per 1,000 population), 2008–2015

Figure 44: Demographics, Colombia, Mortality (per 1,000 population), 2008–2015

Figure 45: Demographics, Colombia, Major Causes of Mortality (%), 2015

Figure 46: Demographics, Colombia, Mortality Rate in Children under Five (per 1,000 live births), 2008–2015

Figure 47: Demographics, Colombia, Immunization Rate (%), 2008–2015

Figure 48: Demographics, Colombia, Major Causes of Male Mortality (‘000), 2011

Figure 49: Demographics, Colombia, Major Causes of Female Mortality (‘000), 2011

Figure 50: Demographics, Colombia, Gender Ratio (M/F), 2008–2015

Figure 51: Demographics, Colombia, Life Expectancy at Birth (years), 2008–2015

Figure 52: Demographics, Colombia, Gross Enrollment by Level of Education (%), 2008–2015

Figure 53: Demographics, Colombia, Unemployment Rate (%), 2008–2015

Figure 54: Demographics, Colombia, Number of Cases by Disease (‘000), 2012

Figure 55: Demographics, Colombia, Disability-Adjusted Life Years by Major Disease (‘000), 2012

Figure 56: Healthcare Infrastructure, Colombia, Hospital Beds (per 1,000 population), 2008–2015

Figure 57: Healthcare Infrastructure, Colombia, Doctors (per 1,000 population), 2008–2015

Figure 58: Healthcare Infrastructure, Colombia, PM2.5 (µg/m3), 2008–2015

Figure 59: Healthcare Infrastructure, Colombia, CO2 Emissions (metric tons per capita), 2008–2015

Figure 60: Healthcare Infrastructure, Colombia, Nurses (per 1,000 population), 2008–2015

Figure 61: Healthcare Infrastructure, Colombia, Dentists (per 1,000 population), 2008–2015

Figure 62: Healthcare Expenditure, Colombia, Healthcare Expenditure (% of GDP), 2008–2015

Figure 63: Healthcare Expenditure, Colombia, Public Healthcare Expenditure, Share of Major Components (%), 2013

Figure 64: Healthcare Expenditure, Colombia, Public–Private Share of Healthcare Expenditure (%), 2008–2015

Figure 65: Healthcare Market, Colombia, Opportunities and Challenges, 2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

The ease of use, and search filters on the GlobalData database are far more detailed which allows you to search at all kinds of different levels

  Adamas Pharmaceuticals, Inc.